HIGHLIGHTS
- who: Xilin Zhang from the Huzhou Key Laboratory of Translational Medicine, First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang, China have published the paper: STRIP2 motivates non-small cell lung cancer progression by modulating the TMBIM6 stability through IGF2BP3 dependent, in the Journal: (JOURNAL)
- what: This study aimed to reveal the biological roles and molecular mechanisms of STRIP2 in the tumorigenesis of NSCLC and proposed that STRIP2 may be a novel potential prognostic biomarker and therapeutic target for NSCLC progression. In the present study, survival analysis using Kaplan-Meier Plotter online datasets revealed that patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.